Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BR55 Ultrasound Molecular Imaging in Prostate Cancer
NCT02142608Phase 2Completed
- Sponsor
- Bracco Diagnostics Inc.
- Start
- Aug 2014
- Primary completion
- Jul 2015
- Modality
- Nanoparticles, Device-based Delivery
- Countries
- 2
01
Overview
A Phase 2 trial of perfluorobutane/nitrogen lipopeptide-coated microbubbles in prostate cancer (PCa), sponsored by Bracco Diagnostics Inc.. Started Aug 2014; status: completed.
02
Drugs
perfluorobutane/nitrogen lipopeptide-coated microbubbles
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02142608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02142608.